112 related articles for article (PubMed ID: 2009320)
1. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Parkins CS; Bush C; Price P; Steel GG
Cell Prolif; 1991 Mar; 24(2):171-9. PubMed ID: 2009320
[TBL] [Abstract][Full Text] [Related]
2. Bromodeoxyuridine labelling of transitional cell carcinoma of the bladder--an index of recurrence?
Popert RJ; Joyce AD; Thomas DJ; Walmsley BH; Coptcoat MJ
Br J Urol; 1993 Mar; 71(3):279-83. PubMed ID: 8477314
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models.
van Weerden WM; Moerings EP; van Kreuningen A; de Jong FH; van Steenbrugge GJ; Schröder FH
Cell Prolif; 1993 Jan; 26(1):67-75. PubMed ID: 8439590
[TBL] [Abstract][Full Text] [Related]
4. Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance.
Bush C; Price P; Norton J; Parkins CS; Bailey MJ; Boyd J; Jones CR; A'Hern RP; Horwich A
Br J Cancer; 1991 Aug; 64(2):357-60. PubMed ID: 1892764
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
van Oostrum IE; Rozemuller E; Knol RF; Erkens-Schulze S; Rutgers DH
Cell Tissue Kinet; 1990 Nov; 23(6):523-44. PubMed ID: 2276171
[TBL] [Abstract][Full Text] [Related]
6. Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.
Bolger BS; Cooke TG; Symonds RP; MacLean AB; Stanton PD
Br J Cancer; 1993 Jul; 68(1):166-71. PubMed ID: 8318408
[TBL] [Abstract][Full Text] [Related]
7. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
9. [Cell cycle analysis using the monoclonal antibody Ki-67].
Isobe H; Shimizu T; Haneda H; Mizuno S; Ishiguro A; Araya Y; Harada M; Miyamoto H; Kawakami Y
Hum Cell; 1988 Jun; 1(2):218-24. PubMed ID: 2979198
[TBL] [Abstract][Full Text] [Related]
10. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
11. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.
Bolger BS; Symonds RP; Stanton PD; MacLean AB; Burnett R; Kelly P; Cooke TG
Br J Cancer; 1996 Oct; 74(8):1223-6. PubMed ID: 8883408
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in proliferation markers in colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B
Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry.
Le Pessot F; Michel P; Paresy M; Lemoine F; Hellot MF; Paillot B; Scotte M; Peillon C; Hemet J
Pathol Res Pract; 2001; 197(6):411-8. PubMed ID: 11432668
[TBL] [Abstract][Full Text] [Related]
15. The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer.
Goodson WH; Moore DH; Ljung BM; Chew K; Florendo C; Mayall B; Smith HS; Waldman FM
Breast Cancer Res Treat; 1998 May; 49(2):155-64. PubMed ID: 9696398
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.
Tsujihashi H; Nakanishi A; Matsuda H; Uejima S; Kurita T
J Urol; 1991 Apr; 145(4):846-9. PubMed ID: 2005717
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 monoclonal antibody (MAb) reacts with a proliferation associated nuclear antigen in the rabbit Oryctolagus cuniculus.
Apte SS
Histochemistry; 1990; 94(2):201-4. PubMed ID: 2358378
[TBL] [Abstract][Full Text] [Related]
18. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa.
Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS
Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome and bromodeoxyuridine-derived proliferation indices in 75 invasive breast carcinomas.
Cutress RI; Mullee MA; Royle GT; Rew DA
Eur J Surg Oncol; 2000 Dec; 26(8):747-50. PubMed ID: 11087639
[TBL] [Abstract][Full Text] [Related]
20. Measuring proliferation in routine fine needle aspirates. Immunocytochemical detection of bromodeoxyuridine incorporation and Ki-67 expression in breast aspirates.
Buley ID; Morrison EH; Kaklamanis L; Horak E; Gatter KC
Cytopathology; 1992; 3(3):149-54. PubMed ID: 1511119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
